News Archive

Researchers hope to develop a test that could detect early changes in blood flow to the heart.

Patients who were moved between hospitals before receiving endovascular therapy were more likely to experience adverse clinical outcomes.

The trial will build off findings from PROMISE and PLATFORM, which looked at similar patient populations and involved many of the same investigators and operational staff.

A new collaboration between the two institutions aims to address continued challenges in access and affordability of cardiovascular care.

The Kevin L. Thomas, MD Scholarship will be awarded to high school students interested in medical careers.

Jessilyn Dunn, PhD, is a faculty member in Duke’s Departments of Biomedical Engineering; Biostatistics and Bioinformatics.

The DCRI has been on the forefront of research into the chronic and fatal lung disease.

Little is known about the cause of idiopathic pulmonary fibrosis (IPF), a devastating disease that

One of the first DCRI studies of its kind could become a model for the future.

An ongoing DCRI clinical trial seeks to determine whether an experimental lipid treatment is effective in preventing a second cardiovascular event in patients who have already had a heart attack.

DCRI biostatisticians play a key role in many of the organization’s projects.